Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Altimmune to Announce Year End 2017 Financial Results on March 29


Posted on: 20 Mar 18

GAITHERSBURG, Md., March 20, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced that it will announce financial results for the quarter and year ended December 31, 2017 before the market open and host a conference call on Thursday, March 29.

Conference Call Details   
Date:  Thursday, March 29
Time:  8:30am Eastern Time
Domestic:  866-548-4713
International:  323-794-2093
Conference ID:  6280732
Webcast:  http://public.viavid.com/index.php?id=128569
    
Replays, Available through April 12th:
Domestic:  844-512-2921
International:  412-317-6671
Replay PIN:   6280732

About Altimmune
Altimmune is a clinical-stage immunotherapeutics company focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of disease including NasoVAX, a Phase 2 seasonal influenza vaccine candidate, and HepTcell, a Phase 1 immunotherapeutic candidate for the potential cure of chronic hepatitis B. The company also has two United States government funded, next-generation anthrax vaccine candidates that are intended to improve protection and safety while having favorable dosage and storage requirements compared to other anthrax vaccines.

Contacts:
Bill Enright                                                                                                          
President and CEO                                                                                         
Phone: 240-654-1450                                                                                      
enright@altimmune.com                                                                             

Ashley Robinson
LifeSci Advisors, LLC
617-535-7742
arr@lifesciadvisors.com

GlobeNewswire
globenewswire.com

Last updated on: 21/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.